Randomized Phase II Study Of Pre-Operative Chemoradiotherapy +/- Panitumumab (Ind #110152) Followed By Consolidation Chemotherapy In Potentially Oper
Posted Date: May 15, 2019
- Investigator: Jordan Kharofa
- Type of Study: Drug
The purpose of this research study is to compare the effects, good and/or bad, of adding panitumumab to chemotherapy and radiation therapy. In this study, you will get chemotherapy and radiation OR radiation, chemotherapy, and panitumumab. Panitumumab has not been approved by the Food and Drug Adm
Criteria:
Eligible Patients Must Have Locally Advanced Non-Small Cell Lung Cancer
Keywords:
Lung Cancer, Non-Small Cell, Nsclc, R0839, Stage 3
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu